For: | Sahebjam F, Hajdu CH, Nortey E, Sigal SH. Direct acting antiviral therapy is curative for chronic hepatitis C/autoimmune hepatitis overlap syndrome. World J Hepatol 2016; 8(14): 632-636 [PMID: 27190580 DOI: 10.4254/wjh.v8.i14.632] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v8/i14/632.htm |
Number | Citing Articles |
1 |
Juan Putra, Thomas D Schiano, M Isabel Fiel. Resolution of HCV-Autoimmune Hepatitis Overlap Syndrome With Antiviral Treatment. American Journal of Clinical Pathology 2019; 152(6): 735 doi: 10.1093/ajcp/aqz095
|
2 |
Kotaro Matsumoto, Kentaro Kikuchi, Yuta Namura, Ayako Watanabe, Hiromichi Tsunashima, Shinpei Doi. Histological improvement in chronic hepatitis C-autoimmune hepatitis overlap syndrome by glecaprevir and pibrentasvir. Clinical Journal of Gastroenterology 2023; 16(4): 572 doi: 10.1007/s12328-023-01809-7
|
3 |
Camila C. Simoes, Omar A. Saldarriaga, Netanya S. Utay, Ashley E. Stueck, Sheharyar K. Merwat, Shehzad N. Merwat, Thomas D. Schiano, Maria Isabel Fiel, Heather L. Stevenson. Direct‐Acting Antiviral Treatment of Patients with Hepatitis C Resolves Serologic and Histopathologic Features of Autoimmune Hepatitis. Hepatology Communications 2019; 3(8): 1113 doi: 10.1002/hep4.1388
|